Baihakki, Benladdin H.
HRN: 11-59-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2025
LEVOFLOXACIN 500MG (TAB)
03/19/2025
03/26/2025
PO
500
OD
Scrotal Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes